Deepa Jewellers, Cotec Healthcare Secure SEBI Nod for IPOs

The Securities and Exchange Board of India (SEBI) has granted approval for initial public offerings (IPOs) to two companies: Deepa Jewellers and Cotec Healthcare. This regulatory clearance marks a significant step for both firms in their ambitions to raise capital from public markets, signaling continued activity in India's primary market. Deepa Jewellers, a Hyderabad-based business-to-business (B2B) operator specializing in hallmarked gold jewellery processing, plans an IPO comprising a fresh issue of shares valued at Rs 250 crore. This fresh capital infusion is typically earmarked for funding future growth initiatives, debt reduction, or working capital requirements. Additionally, the IPO includes an offer for sale (OFS) by existing promoters, which will allow early investors and founders to monetize a portion of their holdings without injecting new capital into the company. Cotec Healthcare, a pharmaceutical Contract Development and Manufacturing Organization (CDMO), also received SEBI's green light. While specific financial details of Cotec Healthcare's IPO, such as the issue size or fresh capital component, were not disclosed in the initial report, the approval positions the company to tap into investor interest in the healthcare and pharmaceutical sectors. CDMOs play a crucial role in the drug development and manufacturing supply chain, offering specialized services that are often in high demand. These approvals underscore SEBI's ongoing role in regulating the capital markets and facilitating corporate fundraising. The successful listing of these companies will contribute to market liquidity and provide new investment avenues for institutional and retail investors. The performance of these IPOs will also serve as a barometer for investor appetite, particularly in the B2B jewellery and pharmaceutical CDMO segments.